Moderna Falls as CDC Panel Shakeup Clouds Vaccine Outlook
The stock price of Moderna decreased by 2.3% on Friday because investors became uncertain about the CDC advisory panel's decision ...
Read moreDetails
© 2025 Newsweek U.S. All rights reserved.
